<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35708789</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Progressive medial temporal degeneration with TDP-43 pathology is associated with upper limb and bulbar onset types of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>5497</StartPage><EndPage>5509</EndPage><MedlinePgn>5497-5509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11217-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to clarify the relationship between progressive medial temporal atrophy and onset subtype in patients with amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Medial temporal atrophy, ALS functional rating scale (ALSFRS), and cognitive function were assessed in 119 patients who were grouped into three ALS subtypes: bulbar, upper limb, and lower limb onset. Medial temporal atrophy, represented by a Z-score, was determined using an analysis software of magnetic resonance images known as the voxel-based specific regional analysis system for Alzheimer's disease (VSRAD). Among 119 patients, 60 underwent follow-up VSRAD, ALSFRS, and cognitive testing. The sequential data were compared among onset subtypes. Furthermore, TDP-43 pathology was assessed in 20 autopsied patients (including seven who underwent VSRAD before death) to examine the relationships among medial temporal atrophy, onset subtypes, and severity of the hippocampal TDP-43 pathology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Multiple regression analysis revealed that the Z-score at baseline was associated with the age of onset and duration of illness. A high Z-score at baseline and the bulbar/upper limb subtypes affected the progression rate of Z-score. Pathological examination revealed increased hippocampal TDP-43 pathology score associated with bulbar and upper limb subtypes. Moreover, the Z-score before death correlated with the hippocampal TDP-43 pathology score.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Medial temporal atrophy in ALS is associated with bulbar and upper limb onset subtypes. This progression may be related to the extent of TDP-43 pathology.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0042-4914</Identifier><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan. takahirotakeda58@yahoo.co.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokubun</LastName><ForeName>Sayuri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Yumiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuneyama</LastName><ForeName>Atsuko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Ai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isose</LastName><ForeName>Sagiri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Kimiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Kimihito</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koreki</LastName><ForeName>Akihiro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, National Hospital Organisation Shimofusa Psychiatric Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugiyama</LastName><ForeName>Atsuhiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuwabara</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Kazuhiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba-shi, Chiba, 260-8712, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Hippocampus</Keyword><Keyword MajorTopicYN="N">Onset type</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">Voxel-based specific regional analysis system for Alzheimer&#x2019;s disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>16</Day><Hour>11</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35708789</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11217-5</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11217-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602&#x2013;611. https://doi.org/10.1016/j.bbrc.2006.10.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130&#x2013;133. https://doi.org/10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE (2005) Prevalence and patterns of&#xa0;cognitive&#xa0;impairment in sporadic ALS. Neurology 65:586&#x2013;590. https://doi.org/10.1212/01.wnl.0000172911.39167.b6</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000172911.39167.b6</ArticleId><ArticleId IdType="pubmed">16116120</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, Tan CF, Onodera O, Toyoshima Y, Yamada M, Morita T, Nishizawa M, Kakita A, Takahashi H (2008) Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 116:169&#x2013;182. https://doi.org/10.1007/s00401-008-0385-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId><ArticleId IdType="pubmed">18481073</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T, Iijima M, Uchihara T, Ohashi T, Seilhean D, Duyckaerts C, Uchiyama S (2015) TDP-43 Pathology progression along the olfactory pathway as a possible substrate for olfactory impairment in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 74:547&#x2013;556. https://doi.org/10.1097/NEN.0000000000000198</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000198</ArticleId><ArticleId IdType="pubmed">25933387</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Hou Y, Li C, Cao B, Cheng Y, Wei Q, Zhang L, Shang H (2021) Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 92:688&#x2013;693. https://doi.org/10.1136/jnnp-2020-325701</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325701</ArticleId><ArticleId IdType="pubmed">33563800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano I (2000) Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology 20:68&#x2013;75</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1789.2000.00272.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T, Uchihara T, Arai N, Mizutani T, Iwata M (2009) Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Acta Neuropathol 117:35&#x2013;44. https://doi.org/10.1007/s00401-008-0447-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0447-2</ArticleId><ArticleId IdType="pubmed">19002475</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, Suh E, Van Deerlin VM, Wood EM, Baek Y, Kwong L, Lee EB, Elman L, McCluskey L, Fang L, Feldengut S, Ludolph AC, Lee VM, Braak H, Trojanowski JQ (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20&#x2013;38. https://doi.org/10.1002/ana.23937</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId><ArticleId IdType="pmc">3785076</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda H (2016) MRI morphometry in Alzheimer&#x2019;s disease. Ageing Res Rev 30:17&#x2013;24. https://doi.org/10.1016/j.arr.2016.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2016.01.003</ArticleId><ArticleId IdType="pubmed">26812213</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, Willey E, Ampong MA, Ellis CM, Shaw CE, Al-Chalabi A, Leigh PN (2009) Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 72:1087&#x2013;1094. https://doi.org/10.1212/01.wnl.0000345041.83406.a2</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000345041.83406.a2</ArticleId><ArticleId IdType="pubmed">19307543</ArticleId><ArticleId IdType="pmc">2821838</ArticleId></ArticleIdList></Reference><Reference><Citation>Inukai Y, Nonaka T, Arai T, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle FE, Akiyama H, Hisanaga S, Hasegawa M (2008) Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett 582:2899&#x2013;2904. https://doi.org/10.1016/j.febslet.2008.07.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.07.027</ArticleId><ArticleId IdType="pubmed">18656473</ArticleId></ArticleIdList></Reference><Reference><Citation>Biernat J, Mandelkow EM, Schr&#xf6;ter C, Lichtenberg-Kraag B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M, Mandelkow E (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 11:1593&#x2013;1597</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1992.tb05204.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Asami-Odaka A, Ishibashi Y, Kikuchi T, Kitada C, Suzuki N (1995) Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 34:10272&#x2013;10278. https://doi.org/10.1021/bi00032a022</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00032a022</ArticleId><ArticleId IdType="pubmed">7640283</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239&#x2013;259. https://doi.org/10.1007/BF00308809</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308809</ArticleId><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389&#x2013;404. https://doi.org/10.1007/s00401-006-0127-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0127-z</ArticleId><ArticleId IdType="pubmed">16906426</ArticleId><ArticleId IdType="pmc">3906709</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal DR, R&#xfc;b U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791&#x2013;1800. https://doi.org/10.1212/wnl.58.12.1791</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.58.12.1791</ArticleId><ArticleId IdType="pubmed">12084879</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Murayama S (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911&#x2013;918. https://doi.org/10.1093/jnen/63.9.911</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/63.9.911</ArticleId><ArticleId IdType="pubmed">15453090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111&#x2013;113. https://doi.org/10.1007/s00401-011-0845-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0845-8</ArticleId><ArticleId IdType="pubmed">21644037</ArticleId><ArticleId IdType="pmc">3285143</ArticleId></ArticleIdList></Reference><Reference><Citation>Insausti R, Amaral DG (2004) Hippocampal formation. In: Paxinos G, Mai J (eds) The Human Nervous System. Academic Press, San Diego, pp 871&#x2013;914</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-012547626-3/50024-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilverman C, Cook SW, Duff MC (2016) Hippocampal declarative memory supports gesture production: evidence from amnesia. Cortex 85:25&#x2013;36. https://doi.org/10.1016/j.cortex.2016.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2016.09.015</ArticleId><ArticleId IdType="pubmed">27810497</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Ven V, Waldorp L, Christoffels I (2020) Hippocampus plays a role in speech feedback processing. Neuroimage 223:117319. https://doi.org/10.1016/j.neuroimage.2020.117319</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117319</ArticleId><ArticleId IdType="pubmed">32882376</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T, Kitagawa K, Arai K (2020) Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology 40:40&#x2013;56. https://doi.org/10.1111/neup.12606</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12606</ArticleId><ArticleId IdType="pubmed">31802540</ArticleId></ArticleIdList></Reference><Reference><Citation>Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755&#x2013;766. https://doi.org/10.1007/s00401-014-1349-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1349-0</ArticleId><ArticleId IdType="pubmed">25348064</ArticleId><ArticleId IdType="pmc">4257842</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Sun B, Wang X, Lu H, Shao F, Rozemuller AJM, Liang H, Liu C, Chen J, Huang M, Zhu K (2019) Phosphorylated TDP-43 staging of primary age-related tauopathy. Neurosci Bull 35:183&#x2013;192. https://doi.org/10.1007/s12264-018-0300-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-018-0300-0</ArticleId><ArticleId IdType="pubmed">30382507</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda H, Mizumura S, Nemoto K, Yamashita F, Imabayashi E, Sato N, Asada T (2012) Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer Disease. AJNR Am J Neuroradiol 33:1109&#x2013;1114. https://doi.org/10.3174/ajnr.A2935</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2935</ArticleId><ArticleId IdType="pubmed">22300935</ArticleId><ArticleId IdType="pmc">8013247</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>